Treatment of colon and rectal cancer

Journal of Clinical Gastroenterology

Volumn 34, Issue 1, 2002, Pages 15-26

  Blumberg, D ^a   Ramanathan, R K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Colon cancer; Radiation; Rectal cancer; Surgery

Indexed keywords

FLUOROPYRIMIDINE; FLUOROURACIL; OXALIPLATIN; THYMIDYLATE SYNTHASE INHIBITOR;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; COLON CANCER; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SALVAGE THERAPY; SURGICAL TECHNIQUE;

COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; IMMUNOTHERAPY; LAPAROSCOPY; RECTAL NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 0036140268     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200201000-00005     Document Type: Review

References (111)

1. Total mesorectal excision: The new golden standard of surgery for rectal cancer
2. The intramural extension of carcinoma of the descending colon, sigmoid and rectosigmoid: A pathologic study
3. Regional mesenteric recurrence of colorectal cancer after anterior resection or left hemicolectomy: Inadequate primary resection demonstrated by angiography of the remaining arterial supply
4. Role of the surgeon as a variable in the treatment of rectal cancer
5. Perforative carcinoma of the colon
6. Penetrating, obstructing, and perforating carcinomas of the colon and rectum
7. Multivisceral resections in colorectal cancer
8. Port site metastasis. An unresolved problem in laparoscopic surgery. A review
9. Port site metastases after laparoscopic colorectal surgery for cure of malignancy
10. Abdominal wall recurrence after laparoscopic colectomy for colon cancer
11. The problem of port-site metastases after laparoscopic cancer surgery
12. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: A preliminary report
13. Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer
14. COLOR: A randomized clinical trial comparing laparoscopic and open resection for colon cancer
15. Laparoscopic approach to colon cancer
16. Current status of laparoscopic colectomy: Is it experimental?
17. The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-1995
18. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
19. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil
20. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
21. Adjuvant therapy for patients with colon rectal cancer
22. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
23. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors
24. Fluorouracil (FU), leucovorin (LV) and levamisol (LEV) adjuvant therapy for colon cancer: Five-year final report INT-0089
25. Efficacy of adjuvant fiuorouracil and folinic acid in B2 colon cancer
26. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
27. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer
28. Portal vein chemotherapy for colorectal cancer: A meta-analysis of 4000 patients in 10 studies
29. Intraperitoneal chemotherapy in the management of colon cancer
30. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: Seven-year outcome of a multicenter randomized trial
31. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer
32. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
33. Liver resection for colorectal metastases
34. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients
35. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from coloructal cancer
36. Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
37. Survival benefit of chemotherapy in metastatic colorectal cancer: A meta-analysis of randomized controlled trials
38. Chemotherapy for colorectal cancer
39. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
40. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolos with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
41. Irinotecan in the treatment of colorectal cancer: Clinical overview
42. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
43. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
44. Developments in fluoropyrimidine therapy for gastrointestinal cancer
45. A Phase III trial of XELODA (capecitabine) in previously untreated advanced/metastatic colorectal cancer
46. Multicenter phase III study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer
47. Oxaliplatin: A review of preclinical and clinical studies
48. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
49. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
50. Thymidylate synthase inhibitors
51. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
52. Final results of a phase I trial of sequential trimetrexate (TMTX), fluorouracil (FU) and high-dose leucovorin (LV) in previously treated patients (pts) with gastrointestinal (GI) carcinoma (CA)
53. K-ras gene mutation as pathogenic and diagnostic marker in human cancer
54. Ras protein farnesyltransfemse: A strategic target for anticancer therapeutic development
55. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
56. Blockade of receptors for growth factors: An anticancer therapy: The fourth annual Joseph H Burchenal American Association of Cancer Res Clinical Research Award Lecture
57. A phase II trial of irinotecan and HERCEPTIN in patients (pts) overexpressing HER-2/neu in metastatic colorectal cancer (CRC)
58. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
59. Tumor angiogenesis: Therapeutic implications
60. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer
61. Tyrosine kinase inhibition: An approach to drug development
62. Matrix metalloproteinases: Biologic activity and clinical implications
63. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
64. Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies
65. A randomized phase II trial comparing rhuMAB VEGF plus 5Flurouracil/leucovorin (FU/LV) to FU/LV alone in patients with metastatic colorectal cancer
66. Stage I rectal cancer: Identification of high-risk patients
67. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997
68. Local recurrence of rectal adenocarcinoma due to inadequate surgical margins, histopathological study of lateral tumor spread and surgical excision
69. Role of circumferential margin involvement in the local recurrence of rectal cancer
70. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer
71. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm
72. Sexual dysfunction following operation for carcinoma of the rectum
73. The quality of life after rectal excision for low rectal cancer
74. Sexual function after resection for rectal cancer
75. Radical and nerve-preserving surgery for rectal cancer in the Netherlands: A prospective study on morbidity and functional outcome
76. Resection of the rectum with construction of a colonic reservoir and colo-anal anastomosis for carcinoma of the rectum
77. Resection and colo-anal anastomosis for carcinoma of the rectum
78. Coloanal anastomosis: Are functional results better with a pouch
79. Prospective randomized trial comparing J colonic pouch-anal anastomosis and straight coloanal reconstruction
80. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection
81. Prospective randomized controlled study of clinical function and anorectaI physiology after low anterior resection: Comparison of straight and colonic J pouch anastomosis
82. Late clinical outcome in a randomised prospective comparison of colonic J pouch and straight coloanal anastomosis
83. Prospective, randomized study comparing clinical results between small and large colonic J-pouch following coloanal anastomosis
84. Prolongation of the disease-free interval in surgically treated rectal cancer
85. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from the NSABP protocol R-01
86. Effective surgical adjuvant therapy for high-risk rectal carcinoma
87. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: Initial results of Intergroup 0114
88. Preoperative radiotherapy as adjuvant treatment in rectal cancer, final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)
89. Concomitant continuous infusion chemotherapy and radiation
90. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy
91. The efficacy of preoperative 5-fluorouracil, high dose leucovorin, and sequential radiation therapy for unresectable cancer
92. Preliminary results of preoperative 5-FU, low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer
93. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03
94. Dose response to preoperative irradiation in rectal cancer: Implications for local control and complications associated with sphincter sparing surgery and abdominal perineal resection
95. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
96. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer
97. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas
98. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation
99. Phase I/II trial of preoperative radiation therapy and coloanal anastomosis in distal invasive resectable rectal cancer
100. Conservative surgery for low rectal carcinoma after high dose radiation. Functional and oncologic results
101. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma: A report from a randomized multicenter trial
102. Surgical approaches to minimize risk of radiation-induced small bowel damage
103. Long-term functional results of coloanal anastomosis for rectal cancer
104. The long term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function
105. Early effect of external beam radiation therapy on the anal sphincter: A study using anal manometry and transrectal ultrasound
106. Chronic effects of pelvic radiation therapy on anorectal function
107. Improved survival with preoperative radiotherapy in resectable rectal cancer
108. Endorectal ultrasonography for the assessment of invasion of rectal tumours and lymph node involvement
109. Transrectal ultrasonography of rectal carcinoma
110. Endorectal ultrasound in the preoperative staging of rectal tumors
111. Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma